Question 1

What are the potential benefits of participating in this trial compared to standard treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) clinical trial (NCT07319195). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the treatments be administered, and what can I expect during the process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) clinical trial (NCT07319195). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of Mitazalimab and Nivolumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) clinical trial (NCT07319195). Contact the study team or your healthcare provider for specific answers.

Question 4

How will participation in this trial affect my surgery schedule?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) clinical trial (NCT07319195). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will I receive during and after the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) clinical trial (NCT07319195). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) clinical trial (NCT07319195). Contact the study team or your healthcare provider for specific answers.

What this study is about